12 | IntegrinsIBA
03/2015
-
05/2008 |
10 | Proteins (Proteins, Gene)FDA Link
05/2022
-
07/2009 |
9 | 1-phenyl-3,3-dimethyltriazene (PDT)IBA
07/2022
-
01/2016 |
9 | Neurotensin Receptors (Neurotensin Receptor)IBA
11/2020
-
07/2014 |
8 | Peptides (Polypeptides)IBA
11/2021
-
05/2008 |
7 | LigandsIBA
01/2022
-
01/2011 |
6 | Pharmaceutical PreparationsIBA
02/2022
-
10/2017 |
5 | NeurotensinIBA
09/2019
-
01/2017 |
4 | DNA (Deoxyribonucleic Acid)IBA
07/2022
-
10/2016 |
4 | Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
02/2022
-
12/2013 |
4 | Biomarkers (Surrogate Marker)IBA
01/2020
-
02/2015 |
4 | Monoclonal AntibodiesIBA
10/2015
-
12/2013 |
3 | Photosensitizing Agents (Photosensitizers)IBA
07/2022
-
03/2016 |
3 | AntigensIBA
01/2022
-
01/2017 |
3 | Biological ProductsIBA
07/2021
-
11/2016 |
3 | ChemokinesIBA
11/2020
-
02/2016 |
3 | Exenatide (Byetta)FDA Link
01/2020
-
08/2011 |
3 | Urethane (Ethyl Carbamate)IBA
01/2019
-
09/2017 |
3 | Member 1 Subfamily B ATP Binding Cassette TransporterIBA
10/2018
-
10/2017 |
3 | Paclitaxel (Taxol)FDA LinkGeneric
02/2016
-
12/2013 |
3 | aspartyl-glycyl-glutamyl-alanineIBA
12/2011
-
07/2011 |
2 | Dextran SulfateIBA
05/2022
-
01/2022 |
2 | InflammasomesIBA
05/2022
-
01/2022 |
2 | AcidsIBA
01/2022
-
07/2009 |
2 | SulfonesIBA
01/2022
-
01/2021 |
2 | InterferonsIBA
12/2021
-
10/2021 |
2 | Radiation-Sensitizing AgentsIBA
11/2021
-
05/2021 |
2 | EnzymesIBA
10/2021
-
07/2021 |
2 | FluorocarbonsIBA
01/2021
-
01/2019 |
2 | CytokinesIBA
11/2020
-
02/2016 |
2 | Fluorouracil (Carac)FDA LinkGeneric
09/2020
-
12/2013 |
2 | 4,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA
01/2020
-
01/2013 |
2 | Glucose (Dextrose)FDA LinkGeneric
01/2020
-
04/2009 |
2 | AndrogensIBA
09/2019
-
09/2012 |
2 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
06/2019
-
01/2018 |
2 | PolymersIBA
01/2019
-
07/2014 |
2 | MicellesIBA
01/2019
-
01/2016 |
2 | Liposomes (Liposome)IBA
09/2018
-
04/2013 |
2 | Cetuximab (Erbitux)FDA Link
11/2017
-
07/2009 |
2 | hydrogen sulfite (bisulfite)IBA
10/2016
-
02/2015 |
2 | Matrix Metalloproteinases (MMPs)IBA
02/2016
-
11/2012 |
2 | Endoplasmic Reticulum Chaperone BiPIBA
06/2015
-
12/2013 |
2 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
10/2014
-
07/2009 |
2 | CY5.5 cyanine dyeIBA
08/2014
-
12/2013 |
2 | Coloring Agents (Dyes)IBA
08/2014
-
01/2013 |
2 | alanyltyrosineIBA
01/2014
-
07/2011 |
2 | AntibodiesIBA
12/2013
-
07/2013 |
2 | EphB4 ReceptorIBA
07/2013
-
01/2013 |
2 | Arabinofuranosyluracil (Ara U)IBA
09/2012
-
07/2011 |
2 | ThymidineIBA
09/2012
-
07/2011 |
1 | protoporphyrin IXIBA
07/2022 |
1 | Autophagy-Related ProteinsIBA
05/2022 |
1 | Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2022 |
1 | c-Mer Tyrosine KinaseIBA
02/2022 |
1 | gallium 68 PSMA-11IBA
01/2022 |
1 | divinyl sulfoneIBA
01/2022 |
1 | BoronIBA
01/2022 |
1 | Phenylalanine (L-Phenylalanine)FDA Link
01/2022 |
1 | Potassium Iodide (Pima)FDA Link
11/2021 |
1 | ElectrolytesIBA
11/2021 |
1 | IodidesIBA
11/2021 |
1 | sodium-iodide symporter (sodium iodide symporter)IBA
11/2021 |
1 | Iodine CompoundsIBA
11/2021 |
1 | Dopamine (Intropin)FDA LinkGeneric
11/2021 |
1 | Tumor Biomarkers (Tumor Markers)IBA
11/2021 |
1 | RacloprideIBA
11/2021 |